Jundishapur Journal of Microbiology

Published by: Kowsar

Frequency of Human Papilloma Virus Genotypes in Patient Samples From Isfahan (Iran) Using Polymerase Chain Reaction Reverse Dot Blot Method

Behnam Toghani Pour 1 , Seyed Masoud Hosseini 1 , * and Mohammad Taghi Kardi 2
Authors Information
1 Department of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, Iran
2 Mahdieh Medical Laboratory, Isfahan, Iran
Article information
  • Jundishapur Journal of Microbiology: April 2017, 10 (4); e37672
  • Published Online: March 5, 2017
  • Article Type: Rapid Communication
  • Received: December 13, 2016
  • Revised: February 4, 2017
  • Accepted: February 25, 2017
  • DOI: 10.5812/jjm.37672

To Cite: Toghani Pour B, Hosseini S M, Taghi Kardi M. Frequency of Human Papilloma Virus Genotypes in Patient Samples From Isfahan (Iran) Using Polymerase Chain Reaction Reverse Dot Blot Method, Jundishapur J Microbiol. 2017 ; 10(4):e37672. doi: 10.5812/jjm.37672.

Copyright © 2017, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Sohrabi A, Mirab-Samiee S, Modarresi MH, Izadimood N, Azadmanesh K, Rahnamaye-Farzami M. Development of in-house multiplex real time PCR for human papillomavirus genotyping in Iranian women with cervical cancer and cervical intraepithelial neoplasia. Asian Pac J Cancer Prev. 2014; 15(15): 6257-61[PubMed]
  • 2. Bharti AC, Shukla S, Mahata S, Hedau S, Das BC. Anti-human papillomavirus therapeutics: facts & future. Indian J Med Res. 2009; 130(3): 296-310[PubMed]
  • 3. Jia H, Wang X, Long Z, Li L. Human papillomavirus infection and cervical dysplasia in female sex workers in Northeast China: an observational study. BMC Public Health. 2015; 15: 695[DOI][PubMed]
  • 4. Raji N, Sadeghizadeh M, Tafreshi KN, Jahanzad E. Detection of human Papillomavirus 18 in cervical cancer samples using PCR-ELISA (DIAPOPS). Iran J Microbiol. 2011; 3(4): 177-82[PubMed]
  • 5. Abreu AL, Souza RP, Gimenes F, Consolaro ME. A review of methods for detect human Papillomavirus infection. Virol J. 2012; 9: 262[DOI][PubMed]
  • 6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90[DOI][PubMed]
  • 7. Laudadio J. Human papillomavirus detection: testing methodologies and their clinical utility in cervical cancer screening. Adv Anat Pathol. 2013; 20(3): 158-67[DOI][PubMed]
  • 8. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst. 2009; 101(7): 475-87[DOI][PubMed]
  • 9. Leung TF, Liu AP, Lim FS, Thollot F, Oh HM, Lee BW, et al. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial. Hum Vaccin Immunother. 2015; 11(7): 1689-702[DOI][PubMed]
  • 10. Schiller JT, Muller M. Next generation prophylactic human papillomavirus vaccines. Lancet Oncol. 2015; 16(5)-25[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments